109 related articles for article (PubMed ID: 9205893)
1. Clinical and technical requirements for proton treatment planning of ocular diseases. The SERAG (South Europe Radiotherapy Group).
Chauvel P; Sauerwein W; Bornfeld N; Friedrichs W; Brassart N; Courdi A; Hérault J; Pignol JP; Bondiau PY; Malandain G
Front Radiat Ther Oncol; 1997; 30():133-42. PubMed ID: 9205893
[No Abstract] [Full Text] [Related]
2. Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning.
Marnitz S; Cordini D; Bendl R; Lemke AJ; Heufelder J; Simiantonakis I; Kluge H; Bechrakis NE; Foerster MH; Hinkelbein W
Strahlenther Onkol; 2006 Jul; 182(7):395-9. PubMed ID: 16826358
[TBL] [Abstract][Full Text] [Related]
3. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
[TBL] [Abstract][Full Text] [Related]
4. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
[TBL] [Abstract][Full Text] [Related]
5. Uveal melanoma: proton beam irradiation.
Gragoudas ES; Marie Lane A
Ophthalmol Clin North Am; 2005 Mar; 18(1):111-8, ix. PubMed ID: 15763196
[TBL] [Abstract][Full Text] [Related]
6. [Criteria for assessing the efficacy of brachytherapy of uveal melanomas, complications of therapy and there prevention].
Brovkina AF; Zarubeí GD; Val'skií VV
Vestn Oftalmol; 1997; 113(3):14-6. PubMed ID: 9265351
[TBL] [Abstract][Full Text] [Related]
7. Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute.
Höcht S; Bechrakis NE; Nausner M; Kreusel KM; Kluge H; Heese J; Heufelder J; Cordini D; Homeyer H; Fuchs H; Martus P; Foerster MH; Wiegel T; Hinkelbein W
Strahlenther Onkol; 2004 Jul; 180(7):419-24. PubMed ID: 15241529
[TBL] [Abstract][Full Text] [Related]
8. Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome.
Seibel I; Cordini D; Rehak M; Hager A; Riechardt AI; Böker A; Heufelder J; Weber A; Gollrad J; Besserer A; Joussen AM
Am J Ophthalmol; 2015 Oct; 160(4):628-36. PubMed ID: 26133249
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic irradiation of uveal melanoma with the Leksell gamma unit.
Zehetmayer M; Menapace R; Kitz K; Ertl A; Strenn K; Ruhswurm I
Front Radiat Ther Oncol; 1997; 30():47-55. PubMed ID: 9205884
[No Abstract] [Full Text] [Related]
10. [Combined radiotherapy of uveal melanoma].
Brovkina AF; Kesheleva VV; Fridman FE; Fishkin IG
Vestn Oftalmol; 1997; 113(2):10-2. PubMed ID: 9229894
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of eye tumors by accelerated proton beams. 7 years experience].
Zografos L; Bercher L; Egger E; Chamot L; Gailloud C; Uffer S; Perret C; Markovits C
Klin Monbl Augenheilkd; 1992 May; 200(5):431-5. PubMed ID: 1319524
[TBL] [Abstract][Full Text] [Related]
12. [Double irradiation for macroscopic radioresistance or recurrence of melanomas of the posterior uvea: clinical, ballistic, therapeutic and prognostic aspects. Series of 19 cases among 462 patients].
Grange JD; Duquesne N; Roubeyrol F; Branisteanu D; Sandon K; Fleury J; Gerard JP; Chauvel P; Pinzaru G; Jean-Louis B; Bievelez B
J Fr Ophtalmol; 1999 Dec; 22(10):1054-63. PubMed ID: 10617843
[TBL] [Abstract][Full Text] [Related]
13. Aspects of enhanced three-dimensional radiotherapy treatment planning.
Ten Haken RK; Fraass BA; Kessler ML; McShan DL
Bull Cancer; 1995 Dec; 82 Suppl 5():592s-600s. PubMed ID: 8680072
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic photon beam irradiation of uveal melanoma: indications and experience at the University of Vienna since 1997.
Dieckmann K; Georg D; Zehetmayer M; Rottenfusser A; Pötter R
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():11-3. PubMed ID: 18166998
[No Abstract] [Full Text] [Related]
15. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
16. Proton beam therapy and iris neovascularisation in uveal melanoma.
Boyd SR; Gittos A; Richter M; Hungerford JL; Errington RD; Cree IA
Eye (Lond); 2006 Jul; 20(7):832-6. PubMed ID: 16167079
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
[TBL] [Abstract][Full Text] [Related]
18. Fundus image fusion in EYEPLAN software: an evaluation of a novel technique for ocular melanoma radiation treatment planning.
Daftari IK; Mishra KK; O'Brien JM; Tsai T; Park SS; Sheen M; Phillips TL
Med Phys; 2010 Oct; 37(10):5199-207. PubMed ID: 21089753
[TBL] [Abstract][Full Text] [Related]
19. Proton or stereotactic photon irradiation for posterior uveal melanoma? A planning intercomparison.
Höcht S; Stark R; Seiler F; Heufelder J; Bechrakis NE; Cordini D; Marnitz S; Kluge H; Foerster MH; Hinkelbein W
Strahlenther Onkol; 2005 Dec; 181(12):783-8. PubMed ID: 16362788
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up after uveal melanoma charged particle therapy.
Char DH; Kroll SM; Castro J
Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
